Naviswiss is entering the Japanese market

Naviswiss has received the regulatory approval for its smart hip navigation which gives orthopedic surgeons additional safety when implanting artificial hip joints. “This regulatory approval is an important milestone”, comments the company on their webpage. It enables Naviswiss to access the Japanese market through already established strong Japanese business partners. First surgeries in Japan are foreseen in the next months.

The company from Aargau is on a global expansion course. Its product is already marketed in Europe, Australia, and Israel and the company has also submitted for FDA clearance to be able to enter the U.S. market.

Naviswiss provides miniaturized surgical navigation systems to aid orthopedic surgeons in accurately implanting artificial joints. The technology detects leg length changes with accuracy to the millimeter solving one of the most common complications for the patient and risks to the medical community with total hip replacements. An additional risk especially with the popular direct anterior approach (DA), lies in the heavy use of radiation to assess implant placement. Naviswiss can reduce or even eliminate the need for radiation for a DA Hip Replacement.